Skip to main content
. Author manuscript; available in PMC: 2009 Sep 2.
Published in final edited form as: Int J Cancer. 2009 Feb 1;124(3):678–686. doi: 10.1002/ijc.23950

TABLE IV.

HAZARD RATIO (HR) FOR QUARTILES OF DIETARY POLYUNSATURATED FATTY ACIDS (PUFAs) IN RELATION TO COLORECTAL CANCER BY STAGE OF DISEASE, AMONG MEN AND WOMEN

Men
Women
Median value (g/1000 kcal) Localized1
Advanced2
Median value (g/1000 kcal) Localized1
Advanced2
Cases, N HR (95% CI)3 Cases, N HR (95% CI)3 Cases, N HR (95% CI)3 Cases, N HR (95% CI)3
Total PUFA
 Q1 3.2 66 1.0 (Ref) 95 1.0 (Ref) 3.3 39 1.0 (Ref) 52 1.0 (Ref)
 Q2 4.2 52 0.94 (0.65–1.36) 66 0.82 (0.60–1.13) 4.3 38 0.97 (0.62–1.52) 64 1.23 (0.85–1.78)
 Q3 5.3 49 0.97 (0.66–1.40) 73 0.99 (0.72–1.34) 5.3 49 1.24 (0.81–1.90) 62 1.20 (0.83–1.75)
 Q4 7.2 43 0.97 (0.65–1.44) 57 0.86 (0.61–1.20) 7.4 40 0.91 (0.58–1.43) 58 1.03 (0.70–1.51)
p for trend 0.89 0.58 0.97 0.95
Total n-3 PUFA
 Q1 0.35 62 1.0 (Ref) 97 1.0 (Ref) 0.36 31 1.0 (Ref) 50 1.0 (Ref)
 Q2 0.45 64 1.27 (0.89–1.80) 65 0.82 (0.60–1.12) 0.46 45 1.35 (0.86–2.14) 53 1.00 (0.68–1.47)
 Q3 0.53 53 1.17 (0.81–1.70) 61 0.87 (0.63–1.20) 0.53 46 1.31 (0.83–2.08) 69 1.24 (0.86–1.79)
 Q4 0.66 31 0.78 (0.51–1.21) 68 1.09 (0.80–1.50) 0.67 44 1.19 (0.75–1.89) 64 1.09 (0.75–1.59)
p for trend 0.41 0.67 0.59 0.43
Marine n-3 PUFA
 Q1 0.09 47 1.0 (Ref) 77 1.0 (Ref)4 0.09 46 1.0 (Ref) 44 1.0 (Ref)4
 Q2 0.15 61 1.37 (0.94–2.01) 66 0.89 (0.64–1.24) 0.15 37 0.79 (0.51–1.21) 56 1.27 (0.86–1.89)
 Q3 0.21 50 1.21 (0.81–1.80) 69 1.00 (0.72–1.38) 0.21 45 0.90 (0.60–1.36) 63 1.37 (0.93–2.01)
 Q4 0.29 52 1.40 (0.94–2.08) 79 1.27 (0.93–1.75) 0.29 38 0.70 (0.45–1.07) 73 1.46 (1.00–2.12)
p for trend 0.17 0.11 0.17 0.05
n-6 PUFA
 Q1 2.8 67 1.0 (Ref) 95 1.0 (Ref) 2.9 40 1.0 (Ref) 54 1.0 (Ref)
 Q2 3.7 49 0.87 (0.60–1.26) 67 0.84 (0.61–1.14) 3.8 34 0.85 (0.53–1.34) 59 1.09 (0.75–1.57)
 Q3 4.7 52 1.01 (0.70–1.46) 72 0.97 (0.71–1.32) 4.7 51 1.26 (0.83–1.91) 64 1.19 (0.82–1.71)
 Q4 6.5 42 0.92 (0.62–1.37) 57 0.85 (0.61–1.19) 6.7 41 0.91 (0.58–1.42) 59 1.01 (0.69–1.47)
p for trend 0.86 0.50 0.87 0.87
Total n-3/n-6 PUFA
 Q1 0.08 48 1.0 (Ref) 62 1.0 (Ref) 0.08 44 1.0 (Ref) 55 1.0 (Ref)
 Q2 0.11 61 1.21 (0.83–1.77) 77 1.20 (0.86–1.68) 0.11 46 1.17 (0.77–1.77) 56 1.11 (0.77–1.62)
 Q3 0.13 55 1.13 (0.76–1.66) 71 1.15 (0.82–1.62) 0.13 39 0.98 (0.64–1.52) 59 1.15 (0.80–1.67)
 Q4 0.16 46 0.93 (0.62–1.41) 81 1.32 (0.94–1.84) 0.16 37 0.82 (0.53–1.28) 66 1.15 (0.80–1.65)
p for trend 0.66 0.15 0.29 0.44
Marine n-3/n-6 PUFA5
 Q1 0.02 49 1.0 (Ref) 55 1.0 (Ref)5 0.02 45 1.0 (Ref) 45 1.0 (Ref)5
 Q2 0.03 51 0.97 (0.66, 1.44) 88 1.48 (1.06, 2.07) 0.03 42 0.95 (0.63, 1.45) 51 1.18 (0.79, 1.76)
 Q3 0.05 54 1.06 (0.72, 1.56) 59 1.03 (0.71, 1.49) 0.05 38 0.83 (0.53, 1.27) 78 1.72 (1.19, 2.49)
 Q4 0.07 56 1.08 (0.73, 1.59) 89 1.54 (1.09, 2.16) 0.07 41 0.86 (0.56, 1.32) 62 1.32 (0.90, 1.95)
p for trend 0.610 0.095 0.383 0.052
1

Localized disease was defined as Dukes A or B.

2

Advanced disease was defined as Dukes C or D.

3

All HRs and 95% confidence intervals (CIs) were adjusted for age at interview (yr), dialect group (Cantonese, Hokkien), interview year (1993–1995, 1996–1998), diabetes at baseline (no, yes), smoking history (never, “heavy” or ≥13 cigarettes per day starting age <15 years, “light” or nonheavy smokers), body mass index (<20, 20–23.9, 24–27.9, ≥28 m/kg2), alcohol intake (0, <7, ≥7 drinks/week), education (no formal education, primary school, secondary school or higher), any weekly physical activity (no, yes), first degree relative diagnosed with colorectal cancer (no, yes), and total daily energy intake (kcal). CI = confidence interval.

4

p for interaction by sex = 0.80.

5

p for interaction by sex = 1.0.